Clinical utility of alpha fetoprotein and HCCR-1, alone or in combination, in patients with chronic hepatitis, liver cirrhosis and hepatocellular carcinoma

Disease Markers

Volumn 30, Issue 6, 2011, Pages 307-315

  Jirun, Peng ^a   Zhang, Guoxin ^b   Kim, Hyun Kee ^c   Ha, Seon Ah ^c   Zhongtian, Jin ^a   Shishi, Qiao ^a   Zhuqingqing, Cui ^a   Lei, Gong ^a   Yoo, Jinah ^c   Kim, Sanghee ^c   Park, Yong Gyu ^c   Wang, Jing ^b   Yang, Yang ^b   Xu, Zekuan ^b   Huang, Zuhu ^b   Lee, Yun Kyung ^c   Song, Eun Young ^d   Kim, Jin Woo ^c  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c The Catholic University of Korea   (South Korea)

^d Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

AFP; biomarker; HCC; HCCR 1

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; ARTICLE; CANCER TISSUE; CHINA; CHRONIC HEPATITIS; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; HUMAN CERVICAL CANCER ONCOGENE 1; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KOREA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; ONCOGENE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

EID: 79960741713     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.3233/DMA-2011-0789     Document Type: Article

References (33)

1. H.B. El-Serag and K.L. Rudolph, Hepatocellular carcinoma: epidemiology and molecular carcinogenesis, Gastroenterolo-gy 132 (2007), 2557-2576. (Pubitemid 46890874)
2. J. Bruix, L. Boix, M. Sala and J.M. Llovet, Focus on hepato-cellular carcinoma, Cancer Cell 5 (2004), 215-219.
3. L. Zhou, J, Liu and F. Luo, Serum tumor markers for detection of hepatocellular carcinoma, World J Gastroenterol 12(8) (2006), 1175-1181.
4. D.M. Parkin, F. Bray, J. Ferlay and P. Pisani, Estimating the world cancer burden: Globocan 2000, Int J Cancer 94 (2001), 153-156. (Pubitemid 32911406)
5. M.C. Kew, Hepatocellular carcinoma. A century of progress, Clin Liver Dis 4 (2000), 257-268.
6. M.-F. Yuen and C.-L. Lai, Serological markers of liver cancer, Best Pract Res Clin Gastroenterol 19(1) (2005), 91-99. (Pubitemid 40331499)
7. J. Bruix, M. Sherman, J.M. Llovet et al., Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver, J Hepatol 35 (2001), 421-430. (Pubitemid 32844200)
8. J.C. Sheu, J.L. Sung, D.S. Chen et al., Early detection of hepa-tocellular carcinoma by real-time ultrasonography. A prospective study, Cancer 56 (1985), 660-666.
9. P.R. Srinivas, B.S. Kramer and S. Srivastava, Trends in biomarker research for cancer detection, Lancet Oncol 2 (2001), 698-704. (Pubitemid 33085816)
10. D. Yao, D. Jiang, Z. Huang et al., Abnormal expressiom of hepatoma specific γ-glutamyl transferase and alteration of γ-glutamyl transferase gene methylation status in patients with hepatocellular carcinoma, Cancer 88 (2000), 761-769. (Pubitemid 30091094)
11. M. Soresi, C. Magliarisi, P. Campagna et al., Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma, Anticancer Res 23 (2003), 1747-1753. (Pubitemid 36750842)
12. H. Liu, P. Li, Y. Zhai et al., Diagnostic value of glypican-3 in serum and liver for primary hepatocellular carcinoma, World J Gastroenterol 16 (2010), 4410-4415.
13. I. Bachtiar, J.M. Santoso, B. Atmanegara et al., Combination of alpha-1-acid glycoprotein and alpha-fetoprotein as an improved diagnostic tool for hepatocellular carcinoma, Clin Chim Acta 399 (2009), 97-101.
14. N.T. Zinkin, F. Grall, K. Bhaskar et al., Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease, Clin Cancer Res 14 (2008), 470-477. (Pubitemid 351226115)
15. S.K. Yoon, N.K. Lim, S.A. Ha et al., The human cervical cancer oncogene protein is a biomarker for human hepatocellular carcinoma, Cancer Res 64 (2004), 5434-5441. (Pubitemid 39006566)
16. D. Geng, J. Chen, L. Chen et al., Effect of matrine on expression of HCCR-1 and HCCR-2 proteins in cultural human hepatocellular carcinomas cells, Chinese J Cancer Res 17(4) (2005), 265-269. (Pubitemid 43074934)
17. J.B. Xia, Z.H. Zhang, Y.J. Tian et al., Cloning, prokaryotic expression and polyclonal antibody preparation of HCCR-1: a new biomarker for hepatocellular carcinoma, Zhonghua Gan Zang Bing Za Zhi 14(2) (2006), 101-104.
18. Y. Yang, G.X. Zhang, R.H. Shi et al., Overexpression of HCCR-1 in hepatocellular carcinoma cells and its clinical significance, Zhonghua Gan Zang Bing Za Zhi 15(3) (2007), 223-224.
19. J. Ko, Y.H. Lee, S.Y. Hwang et al., Identification and differential expression of novel human cervical cancer oncogene HCCR-2 in human cancers and its involvement in p53 stabilization, Oncogene 22 (2003), 4679-4689. (Pubitemid 36976443)
20. J. Ko, S.M. Shin, Y.M. Oh et al., Transgenic mouse model for breast cancer: induction of breast cancer in novel oncogene HCCR-2 transgenic mice, Oncogene 23 (2004), 1950-1953. (Pubitemid 38445421)
21. G.W. Cho, S.M. Shin, H. Namkoong et al., The phosphatidyli-nositol 3-kinase/Akt pathway regulates the HCCR-1 oncogene expression, Gene 384 (2006), 18-26. (Pubitemid 44738325)
22. J.N. Vauthey, G.Y. Lauwers, N.F. Esnaola et al., Simplified staging for hepatocellular carcinoma, J Clin Oncol 20(6) (2002), 1527-1536. (Pubitemid 34260532)
23. AJCC, AJCC Cancer Staging Manual, 6th ed., Springer, New York, 2002.
24. F.X. Bosch, J. Ribes, R. Cleries and M. Diaz, Epidemiology of hepatocellular carcinoma, Clin Liver Dis 9 (2005), 191-211.
25. C. Verhoef, O. Visser, R.A. de Man et al., Hepatocellular carcinoma in, the Netherlands incidence, treatment and survival patterns, Eur J Cancer 40 (2004), 1530-1538. (Pubitemid 38757741)
26. M.A. Avila, C. Berasain, B. Sangro and J. Prieto, New therapies for hepatocellular carcinoma, Oncogene 25 (2006), 3866-3884. (Pubitemid 43980482)
27. P.J. Johnson, R. Williams, H. Thomas, S. Sherlock and I.M. Murray-Lyon, Induction of remission in hepatocellular carcinoma with doxorubicin, Lancet 1 (1978), 1006-1009. (Pubitemid 8342858)
28. G.I. Abelev, S.D. Perova, N.I. Khramkova, Z.A. Postniko-va and I.S. Irlin, Production of embryonal alpha-globulin by transplantable mouse hepatomas, Transplantation 1 (1963), 174-180.
29. S. Gupta, S. Bent and J. Kohlwes, Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis, Ann Intern Med 139 (2003), 46-50. (Pubitemid 38124619)
30. P.J. Johnson and R. Williams, Serum alpha-fetoprotein estimations and doubling time in hepatocellular carcinoma: Influence of therapy and possible value in early detection, J Nat Cancer Inst 64 (1980), 1329-1332. (Pubitemid 10109725)
31. P.J. Johnson, The Role of Serum Alpha-fetoprotein Estimation in the Diagnosis and Management of Hepatocellular Carcinoma, in: Clinics in Liver Disease, (Vol. 5), A. Di Bisceglie, ed., WB Saunders, Philadelphia, 2001, pp. 145-159. (Pubitemid 32118643)
32. M. Sherman, Alphafetoprotein: an obituary, J Hepatol 34 (2001), 603-605. (Pubitemid 32328519)
33. M.F. Yuen, C.L. Lai, Serological markers of liver cancer, Best Pract Res Clin Gastroenterol 19 (2005), 91-99.